In patient-derived GBM organoids (GBOs) and brain slices, tumor cells engaged in synaptic-like interactions with glutamatergic and cholinergic neurons, with cholinergic signaling via the CHRM3 accelerating proliferation. The gene discussed is CHRM3; the disease is neoplasm.